Synthesis of basic fibroblast growth factor by murine mast cells. Regulation by transforming growth factor beta, tumor necrosis factor alpha, and stem cell factor

International Archives of Allergy and Immunology

Volumn 115, Issue 1, 1998, Pages 47-54

  Qu, Zhenhong ^a,b,c   Huang, Xiaona ^a   Ahmadi, Proochista ^a   Stenberg, Paula ^a   Liebler, Janice M ^a   Le, Anh Chi ^a   Planck, Stephen R ^a,b   Rosenbaum, James T ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Fibroblast growth factor; Mast cell; Stem cell factor; Transforming growth factor; Tumor necrosis factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; MESSENGER RNA; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAST CELL; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; DOWN-REGULATION; FIBROBLAST GROWTH FACTOR 2; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNOHISTOCHEMISTRY; MAST CELLS; MICE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031964579     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023829     Document Type: Article

References (33)

1. Gruber BL, Kaplan AP: Mast cells and rheumatic diseases; in McCarty DJ (ed): Arthritis and Allied Conditions. Philadelphia, Lea & Febiger, 1993, pp 417-436.
2. Schulman ES: The role of mast cells in inflammatory responses in the lung. Crit Rev Immunol 1993;131:35-70.
3. Claman HN: Mast cells and fibrosis. The relevance to scleroderma. Rheum Dis Clin North Am 1990;16:141-151.
4. Claman HN: Mast cells and fibrosis. Hints from graft-versus-host disease and scleroderma; in Kaliner MA, Metcalf DD (eds): The Mast Cell in Health and Disease. New York, Dekker, 1993, vol 62, pp 653-668.
5. Qu Z, Liebler JM, Powers MR, Galey T, Ahmadi P, Huang XN, Ansel JC, Butterfield JH, Planck SR Rosenbaum JT: Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 1995;147:564-573.
6. Reed JA, Albino AP, McNutt NS: Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest 1995;72:215-222.
7. Gonzalaz A-M, Buscaliga M, Fox R, Isacchi A, Sarmientos P, Farris J, Ong M, Martineau D, Lappi DA, Baird A: Basic fibroblast growth factor in Dupuytren's contracture. Am J Pathol 1992;141:661-671.
8. Henke C, Marineili W, Jessurun J, Fox J, Harms D, Peterson M, Chiang L, Doran P: Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury. Am J Pathol 1993; 143:1189-1199.
9. Charlotte F, Win KM, Preaux AM, Mavier P, Dhumeaux D, Zafrani ES, Rosenbaum J: Immunolocalization of heparin-binding growth factors (HBGF) types 1 and 2 in rat liver: Selective hyperexpression of HBGF-2 in carbon tetrachloride-induced fibrosis. J Pathol 1993;169: 471-476.
10. Schwartz LB: Heterogeneity of human mast cells; in Kaliner MA, Metcalfe DD (eds): The Mast Cell in Health and Disease. New York, Dekker, 1993, vol 62, pp 219-236.
11. Katz HR, Kaye RE, Austen KF: Mast cell biochemical and functional heterogeneity. Transplant Proc 1991;23:2900-2904.
12. Weidner N, Austen KF: Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content. Pathol Res Prac 1993;189:156-162.
13. Bradding P, Okayama Y, Howarth PH, Church MK, Holgate ST: Heterogeneity of human mast cells based on cytokine content. J Immunol 1995;155:297-307.
14. Brown MA, Pierce JH, Watson CJ, Falco J, Ihle JN, Paul WE: B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell 1987;50:809-818.
15. Ansel JC, Brown JR, Payan DG, Brown MA: Substance P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol 1993;150:4478-4485.
16. Wray W, Boulikas T, Wray VP, Hancock R: Silver staining of protein in polyacrylamide gels. Anal Biochem 1981;118:197-203.
17. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
18. Levi-Schaffer F, Dayton ET, Austen KF, Hein A, Caulfied JP, Gravallese PM, Liu FT, Stevens RL: Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2. J Immunol 1987;139:3431-3441.
19. Qu Z, Huang X-N, Andresevic J, Ahmadi P, Planck SR, Hart CE, Rosenbaum JT: Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease. Lab Invest 1995;73:339-346.
20. Gruber BL, Marchese MJ, Kew R: Angiogenic factors stimulate mast-cell migration. Blood 1995;86:2488-2493.
21. Flanagan JG, Chan DC, Leder P: Transmembrane form of the kit ligand growth factors is determined by alternative splicing and is missing in the Sld mutant. Cell 1991;64:1025-1035.
22. Nocka K, Buck J, Levi E, Besmer P: Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. EMBO J 1990;9:3287-3294.
23. Kirshenbaum AS, Goff JP, Albert JP, Kessler SW, Metcalfe DD: Fibroblasts determine the fate of Fc epsilon RI+ cell populations in vitro by selectively supporting the viability of mast cells while internalizing and degrading basophils. Int Arch Allergy Immunol 1994;105: 374-380.
24. Gabbianelli M, Sargiacomo M, Pelosi E, Testa U, Isacchi G, Peschle C: 'Pure' human hematopoietic progenitors: Permissive action of basic fibroblast growth factor. Science 1990;249: 1561-1564.
25. Gabrilove JL, White K, Rahman Z, Wilson EL: Stem cell factor and basic fibroblast growth factor are synergistic in augmenting committed myeloid progenitor cell growth. Blood 1994;83: 907-910.
26. Kirshenbaum As, Kessler SW, Goff JP, Metcalfe DD: Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol 1991;146:1410-1415.
27. Florkiewicz RZ, Sommer A: Human basic fibroblast growth factor gene encodes four polypeptides: Three initiate translation from non-AUG codons. Proc Natl Acad Sci USA 1989; 86:3978-3981.
28. Brigstock DR, Klagsbrun M, Sasse J, Farber PA, Iberg N: Species-specific high molecular weight forms of basic fibroblast growth factor. Growth Factors 1990;4:45-52.
29. Renko M, Quarto N, Morimoto T, Rifkin DB: Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J Cell Physiol 1990;144:108-114.
30. Gajdusek CM, Luo Z, Mayberg MR: Basic fibroblast growth factor and transforming growth factor beta-1. Synergistic mediators of angiogenesis in vitro. J Cell Physiol 1993;157:133-144.
31. Gordon JR, Galli SJ: Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachetin. Nature 1990;346:274-276.
32. Quaglino DJ, Nanney LB, Ditesheim JA, Davidson JM: Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin: Incisional wound model. J Invest Dermatol 1991; 97:34-42.
33. Goldsmith KT, Gammon RB, Garver RI Jr: Modulation of bFGF in lung fibroblasts by TGF-beta and PDGF. Am J Physiol 1991; 261:L378-L385.